Dr. Songhui Ma is a physician specializing in the field of Allergy and Clinical Immunology. She is board certified by the American Board of Allergy and Immunology and completed her allergy training at the Mount Sinai Medical Center. She is on the faculty of both the New York University School of Medicine where she teaches medical students and the Mount Sinai School of Medicine where she teaches in the allergy fellowship program. She received her undergraduate degree from Columbia College and her medical degree from the New York University School of Medicine. She has been in practice since 2003 and founded Empire Allergy and Asthma in 2005.
She sees both adults and children with a wide range of allergy problems including allergic rhinitis, asthma and sinus disease as well as food, drug and skin allergies.
Address and Contact Information
Empire Allergy and Asthma, P.C.
154 West 14th Street, 4th floor
New York, NY 10011
Phone: 212-342-7410
Fax: 212-342-7411
Email: drma@empireallergy.com
Education |
|
| 9/94-6/98 | New York University School of Medicine, New York, NY Doctor of Medicine |
| 9/88-5/92 | Columbia University, New York, NY Bachelor of Arts, American History |
Training |
|
| 7/01-6/03 | Mount Sinai Medical Center, New York, NY Fellowship in Allergy and Clinical Immunology |
| 7/98-6/01 | Mount Sinai Medical Center, New York, NY Internship and Residency in Internal Medicine |
Work History |
|
| 11/05-present | Empire Allergy and Asthma, P.C., New York, NY |
| 6/08-present | Bellevue Hospital Allergy Clinic, New York, NY |
| 8/05-2/10 | Allergy and Asthma Care of New York, New York, NY |
| 7/03-6/05 | Atlantic Allergy, Asthma and Immunology, L.L.C., Ocean, NJ |
Certification
Diplomate in Allergy and Immunology, board certified since August 2003
by American Board of Allergy and Immunology
Diplomate in Internal Medicine, board certified since August 2001
by American Board of Internal Medicine
Licensure
New York State Medical License issued July 1999, active
Federal Drug Enforcement Agency issued August 2003, active
New Jersey State Medical License issued June 2003, inactive
Hospital Appointments |
|
| 1/09-present | Beth Israel Medical Center, New York, NY Department of Medicine, Clinical Attending |
| 2/08-present | New York University School of Medicine, New York, NY Department of Medicine, Clinical Instructor |
| 2/05-present | Mount Sinai Medical Center, New York, NY Departments of Medicine and Pediatrics, Clinical Instructor |
| 11/04-4/10 | Saint Vincent’s Medical Center, New York, NY Department of Medicine, Assistant Attending |
| 12/03-6/05 | Monmouth Medical Center, Long Branch, NJ, Staff Physcian |
| 12/03-6/05 | Jersey Shore Medical Center, Neptune, NJ, Staff Physician |
| 1/04-6/05 | Riverview Medical Center, Red Bank, NJ Staff Physician |
Medical Societies |
| American Academy of Allergy, Asthma and Immunology |
| American College of Allergy, Asthma and Immunology |
| New York Allergy and Asthma Society |
Research Experience
2005 GlaxoSmithKline FFR30002: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100 mcg for 4 Weeks in Adult and Adolescent Subjects (12 years of age) with Perennial Allergic Rhinitis (PAR).
2005 GlaxoSmithKline FFR100010: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 50 mcg and 100 mcg for 2 Weeks in Pediatric Subjects 2 to 12 Years with Seasonal Allergic Rhinitis (SAR).
2005 Sanofi-Aventis AVE2635A: A placebo- and active-controlled (ciclenoside metered-dose inhaler), randomized, parallel-group, dose-range finding study of ciclenoside administered by dry powder inhaler (Ultrahaler) in adult and adolescent patients with persistent asthma.
2005 Medpointe MP426: Randomized Double-Blind Trial of Astelin (azelastine hydrochloride) Nasal Spray Compared to Zyrtec (cetirizine hydrochloride) in Patients with Seasonal Allergic Rhinitis.
2004-2005 Merck 008: A Multicenter, Randomized, Double-Blind, Crossover Study Comparing the Effect of L-000888839 Plus Montelukast in Adult Patients with Chronic Asthma.
2004 Medpointe MP425: A Randomized Double-Blind Trial of Astelin (azelastine hydrochloride) Nasal Spray Compared to Zyrtec (cetirizine), in Patients with Seasonal Allergic Rhinitis.
2004 Aventis XRP1526B-3027: A Multicenter, Multinational, Randomized, Double-Blind, Parallel-Group Study of the Effects of Ciclesonide HFA-MDI 640g/day and Beclomethasone HF-MDI 640g/day on Lens Opacification in Adult Subjects with Moderate to Severe Persistent Asthma
2003 Merck 265: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Investigating the Clinical Effects of Montelukast in Patients with Perennial Allergic Rhinits.
2003 Astra-Zeneca SD-030-0726: A Twelve Week, Randomized, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Study of Symbicort pMDI Administered Once Daily in Adults and Adolescents with Asthma.
2003 Merck 005: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the Clinical Effect of L-00088839 in Patients with Seasonal Allergic Rhinitis.
2003 B-Cell Maturation in Common Variable Immunodeficiency with C. Cunningham-Rundles, Mount Sinai Medical Center: Correlation of total immunoglobulin levels, specific antibody production and clinical characteristics of patients with common variable immunodeficiency with CD27 expression.
2001-2004 Clinical Characteristics and Management of Fruit and Vegetable Allergy with A. Nowak-Wegrzyn and H. Sampson, Mount Sinai Medical Center: Survey of practicing allergists regarding clinical management of and risk of progression to systemic allergy among patients with oral allergy syndrome. Characterization of fruit and vegetable allergy in children and its relationship with pollen hypersensitivity. Efficacy of birch and ragweed immunotherapy for treatment of pollen-fruit hypersensitivity.
2002-2003 Casual Contact Reactions in Peanut Allergic Children with S. Sicherer, Mount Sinai Medical Center: Assessment of anaphylaxis risk due to skin contact or inhalation of peanut.
2001-2003 Treatment of Leukocyte Adhesion Deficiency Type 2 with P. Frenette and C. Cunningham-Rundles, Mount Sinai Medical Center: Restoration of immunologic function using oral fucose supplementation in a patient with leukocyte adhesion deficiency type 2, a disorder of fucose metabolism that leads to recurrent infections and developmental delay.
2001-2002 Baxter 309801: A Phase 3 Study to Determine the Efficacy and Safety of C1-Inhibitor (Human) Vapor Heated, Immuno in Subjects with Hereditary Angioedema (HAE).
1995-1997 Transcriptional Control of Keratin Genes with M. Blumenberg and I. Freedberg, New York University Medical Center: Regulatory mechanisms of expression of keratins, cytoskeletal proteins unique to keratinocytes and markers of differentiation and inflammation.
Publications
A. Hidalgo, S. Ma, A. Peired, L. Weiss, C. Cunningham-Rundles and P. Frenette, Insights into Leukocyte Adhesion Deficiency Type II from a Novel Mutation in the GDP-Fucose Transporter Gene, Blood, 101(5):1705-1712, 2003.
S. Ma, A. Hidalgo, S. Simonte, P. Frenette, C. Cunningham-Rundles, Leukocyte Adhesion Deficiency Type 2 and Fucose Therapy: A New Case, abstract, Clinical Immunology, 103(2):S37-8, 2002.
S. Ma and L. Mayer, Immunodeficiency Diseases, in R. Coico et al., editors, ImmunoPDA Library, BiomedicalPDA, 2001-2002, Professional PDA Publishing, LLC and John Wiley and Sons, Inc.
S. Ma and A. Nowak-Wegrzyn, Fruit and Vegetable Allergy in Children, abstract, Journal of Allergy and Clinical Immunology, 113(2):S146, 2004.
S. Ma, A. Nowak-Wegrzyn and H. Sampson, Management of Oral Allergy Syndrome in Allergy Practices, Journal of Allergy and Clinical Immunology, 112(4):784-8, 2003.
S. Ma, L. Rao, I. Freedberg, M. Blumenberg, Transcriptional Control of the Keratin K5, K6, K14 and K17 Genes by AP-1 and NF-B Family Members, Gene Expression, 6:361-370, 1997.
A. Nowak-Wegrzyn, S. Mofidi, S. Ma, L. Bardina and K. Beyer, Birch and Ragweed Pollen Immunotherapy in the Treatment of Pollen-Fruit Allergy Syndrome, abstract, Journal of Allergy and Clinical Immunology, 113(2):S146, 2004.
S. Simonte, S. Ma, S. Mofidi and S. Sicherer, Relevance of Casual Contact with Peanut Butter in Children with Peanut Allergy, Journal of Allergy and Clinical Immunology, 112(1):180-182, 2003.
